The induction of growth arrest and apoptosis by PPARγ agonists was associated with the expression of PPARγ and inhibition of Tyk2-Stat3 signalling pathway in BTSCs, further suggesting the use of PPARγ agonists in the treatment of brain tumours. Here, PPARG is linked to brain neoplasm.